Cargando…

Hormonal treatment for endometriosis associated pelvic pain

BACKGROUND: Endometriosis is a common gynecological problem associated with chronic pelvic pain. OBJECTIVE: To evaluate the effectiveness of current hormonal treatments of endometriosis associated pain. MATERIALS AND METHODS: Randomized Controlled studies identified from databases of Medline and Coc...

Descripción completa

Detalles Bibliográficos
Autores principales: Felix Wong, Wu Shun, Danforn Lim, Chi Eung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575749/
https://www.ncbi.nlm.nih.gov/pubmed/26396559
_version_ 1782390811775729664
author Felix Wong, Wu Shun
Danforn Lim, Chi Eung
author_facet Felix Wong, Wu Shun
Danforn Lim, Chi Eung
author_sort Felix Wong, Wu Shun
collection PubMed
description BACKGROUND: Endometriosis is a common gynecological problem associated with chronic pelvic pain. OBJECTIVE: To evaluate the effectiveness of current hormonal treatments of endometriosis associated pain. MATERIALS AND METHODS: Randomized Controlled studies identified from databases of Medline and Cochrane Systemic Review groups were pooled. 7 RCTs were recruited for evaluation in this review. Data from these studies were pooled and meta-analysis was performed in three comparison groups: 1) Progestogen versus GnRHa; 2) Implanon versus Progestogen (injection); 3) Combined oral contraceptive pills versus placebo and progestogen. Response to treatment was measured as a reduction in pain score. Pain improvement was defined as improvement ≥1 at the end of treatment. RESULTS: There was no significant difference between treatment groups of progestogen and GnRHa (RR: 0.036; CI:-0.030-0.102) for relieving endometriosis associated pelvic pain. Long acting progestogen (Implanon) and Mirena are not inferior to GnRHa and depot medroxy progesterone acetate (DMPA) (RR: 0.006; CI:-0.142-0.162). Combined oral contraceptive pills demonstrated effective treatment of relieving endometriosis associated pelvic pain when compared with placebo groups (RR:0.321CI-0.066-0.707). Progestogen was more effective than combined oral contraceptive pills in controlling dysmenorrhea (RR:-0.160; CI:-0.386-0.066), however, progestogen is associated with more side effects like spotting and bloating than the combined contraceptive pills. CONCLUSION: Combined oral contraceptive pills (COCP), GnRHa and progestogens are equally effective in relieving endometriosis associated pelvic pain. COCP and progestogens are relatively cheap and more suitable for long-term use as compared to GnRHa. Long-term RCT of medicated contraceptive devices like Mirena and Implanon are required to evaluate their long-term effects on relieving the endometriosis associated pelvic pain.
format Online
Article
Text
id pubmed-4575749
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Research and Clinical Center for Infertility
record_format MEDLINE/PubMed
spelling pubmed-45757492015-09-22 Hormonal treatment for endometriosis associated pelvic pain Felix Wong, Wu Shun Danforn Lim, Chi Eung Iran J Reprod Med Review Article BACKGROUND: Endometriosis is a common gynecological problem associated with chronic pelvic pain. OBJECTIVE: To evaluate the effectiveness of current hormonal treatments of endometriosis associated pain. MATERIALS AND METHODS: Randomized Controlled studies identified from databases of Medline and Cochrane Systemic Review groups were pooled. 7 RCTs were recruited for evaluation in this review. Data from these studies were pooled and meta-analysis was performed in three comparison groups: 1) Progestogen versus GnRHa; 2) Implanon versus Progestogen (injection); 3) Combined oral contraceptive pills versus placebo and progestogen. Response to treatment was measured as a reduction in pain score. Pain improvement was defined as improvement ≥1 at the end of treatment. RESULTS: There was no significant difference between treatment groups of progestogen and GnRHa (RR: 0.036; CI:-0.030-0.102) for relieving endometriosis associated pelvic pain. Long acting progestogen (Implanon) and Mirena are not inferior to GnRHa and depot medroxy progesterone acetate (DMPA) (RR: 0.006; CI:-0.142-0.162). Combined oral contraceptive pills demonstrated effective treatment of relieving endometriosis associated pelvic pain when compared with placebo groups (RR:0.321CI-0.066-0.707). Progestogen was more effective than combined oral contraceptive pills in controlling dysmenorrhea (RR:-0.160; CI:-0.386-0.066), however, progestogen is associated with more side effects like spotting and bloating than the combined contraceptive pills. CONCLUSION: Combined oral contraceptive pills (COCP), GnRHa and progestogens are equally effective in relieving endometriosis associated pelvic pain. COCP and progestogens are relatively cheap and more suitable for long-term use as compared to GnRHa. Long-term RCT of medicated contraceptive devices like Mirena and Implanon are required to evaluate their long-term effects on relieving the endometriosis associated pelvic pain. Research and Clinical Center for Infertility 2011 /pmc/articles/PMC4575749/ /pubmed/26396559 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Felix Wong, Wu Shun
Danforn Lim, Chi Eung
Hormonal treatment for endometriosis associated pelvic pain
title Hormonal treatment for endometriosis associated pelvic pain
title_full Hormonal treatment for endometriosis associated pelvic pain
title_fullStr Hormonal treatment for endometriosis associated pelvic pain
title_full_unstemmed Hormonal treatment for endometriosis associated pelvic pain
title_short Hormonal treatment for endometriosis associated pelvic pain
title_sort hormonal treatment for endometriosis associated pelvic pain
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575749/
https://www.ncbi.nlm.nih.gov/pubmed/26396559
work_keys_str_mv AT felixwongwushun hormonaltreatmentforendometriosisassociatedpelvicpain
AT danfornlimchieung hormonaltreatmentforendometriosisassociatedpelvicpain